April 19, 2022
1 min watch
Save
VIDEO: Methotrexate dosing in patients with obesity
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
BOSTON – Loriel J. Solodokin, PharmD, BCOP, talked about the “innovative research” presented at the poster sessions at Hematology/Oncology Pharmacy Association Annual Meeting in a video interview.
Solodokin, assistant professor of pharmacy practice at MCPHS University School of Pharmacy-Boston and pharmacy specialist-hematology/oncology at Dana Farber Cancer Institute/Brigham and Women's Hospital, discussed posters on methotrexate dosing in patients with obesity, managing ocular toxicities of belantamab in real-world settings and using ursodiol for the management of graft-versus-host disease of the liver.
Published by:
Sources/Disclosures
Collapse
Source:
Poster Sessions. Presented at: HOPA Annual Conference; Mar. 30-Apr. 2, 2022; Boston.
Disclosures:
Solodokin reports no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.